Prevalence and incidence of retinopathy in elderly diabetic patients receiving early diagnosis and treatment

Experimental and Therapeutic Medicine

Volumn 5, Issue 5, 2013, Pages 1393-1396

  Li, Xin ^a   Wang, Zhaoyan ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Diabetes; Diabetic retinopathy; Elderly; Incidence; Prevalence

Indexed keywords

ACETYLSALICYLIC ACID; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VITAMIN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; DIABETES MELLITUS; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; EARLY DIAGNOSIS; EYE EXAMINATION; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MICROALBUMINURIA; MICROANEURYSM; MYDRIASIS; PREVALENCE; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA NEOVASCULARIZATION; RISK FACTOR;

EID: 84876545452     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.1021     Document Type: Article

References (23)

1. Klein BE: Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol 14: 179-183, 2007.
2. Zhang CF and Zui RF: Diabetic retinopathy. In: Diseases of Ocular Fundus. People's Medical Publishing House, Beijing, China, pp223-255, 2010.
3. Reichard P, Berglund B, Britz A, Cars I, Nilsson BY and Rosenqvist U: Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years. J Intern Med 230: 101-108, 1991.
4. Bloomgarden ZT: Screening for and managing diabetic retinopathy: current approaches. Am J Health Syst Pharm 64 (Suppl 12): S8-S14, 2007.
5. Kempen JH, O'Colmain BJ, Leske MC, et al: The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol 122: 552-563, 2004.
6. Wu CR, Xu ZR, Hu LN, Wang YZ, Jing H and Luo L: Risk factors of proliferative diabetic retinopathy in type 2 diabetes. Chinese Journal of Ocular Fundus Diseases 19: 338-340, 2003 (In Chinese).
7. Delcourt C, Vauzelle KF, Cathelineau G and Papoz L; CODIAB-INSERM-ZENECA Pharma Study Group: Low prevalence of long-term complications in non-insulin-dependent diabetes mellitus in France: a multicenter study. J Diabetes Complications 12: 88-95, 1998.
8. Klein R, Klein BEK and Moss SE: The Wisconsin epidemiological study of diabetic retinopathy: a review. Diab Met Rev 5: 559-570, 1989.
9. Dowse GK, Humphrey AR, Collis VR, et al: Prevalence and risk factors for diabetic retinopathy in the multi-ethnic population of Mauritius. Am J Epidemol 147: 448-457, 1998.
10. Tapp RJ, Shaw JE, Harper CA, et al: The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care 26: 1731-1737, 2003.
11. Chen XF and Yu YR: Analysis of the complications and accompanied diseases of diabetic inpatients in West China Hospital, 1996-2005. Chin J Diabetes 17: 597-600, 2009 (In Chinese).
12. Pan CY, Tian H, Xu XJ and Lu JM: Prevalence and incidence of diabetes in the elderly in Beijing army. Chin J Geriatr 22: 364-367, 2003 (In Chinese).
13. Yang W, Lu J, Weng J, et al: Prevalence of diabetes among men and women in China. N Engl J Med 362: 1090-1101, 2010.
14. Zheng SX: Diabetes in 2007: epidemiology and etiology. Intern J Endocrinol Metab 28: 1-7, 2008.
15. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986, 1993.
16. Turner R, Cull C and Holman R: United Kingdom Prospective Diabetes Study 17: a nine-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med 124: 136-145, 1996.
17. van Leiden HA, Dekker JM, Moll AC, et al: Blood pressure, lipids and obesity are associated with retinopathy: the Hoorn Study. Diabetes Care 25: 1320-1325, 2002.
18. Stratton IM, Cull CA, Adler AI, Matthews DR, Neil NA and Holman RR: Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia 49: 1761-1769, 2006.
19. Garancini P, Moffitt P, Valsania P, et al: Prevalence of retinopathy in diabetic subjects from out-patient clinics in Lombardy (Italy), and associated risk factors. A multicenter epidemiologic study. Diabetes Res Clin Pract 6: 129-138, 1989.
20. UK Prospective Diabetes Study (UKPDS) Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352: 854-865, 1998.
21. Xie XW, Xu L, Jonas JB and Wang YX: Prevalence of diabetic retinopathy among subjects with known diabetes in China: the Beijing Eye Study. Eur J Ophthalmol 19: 91-99, 2009.
22. Scanlon PH: The English national screening programme for sight-threatening diabetic retinopathy. J Med Screen 15: 1-4, 2008.
23. Stefánsson E, Bek T, Porta M, et al: Screening and prevention of diabetic blindness. Acta Ophthalmol Scand 78: 374-385, 2000.